Abiraterone Acetate Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Condition: Castration-Resistant Prostatic Cancer Interventions: Drug: Niraparib; Drug: Abiraterone acetate (AA); Drug: Prednisone; Drug: Placebo for Niraparib Sponsor: Janssen Research & Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2020 Category: Research Source Type: clinical trials

Abiraterone Acetate in Combination With Tildrakizumab
Condition: Metastatic Castration Resistant Prostate Cancer Interventions: Drug: Abiraterone Acetate; Drug: Tildrakizumab Sponsors: Institute of Cancer Research, United Kingdom; Sun Pharma Global FZE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2020 Category: Research Source Type: clinical trials

A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol
Condition: Metastatic Castration-resistant Prostate Cancer Intervention: Other: Serum and plasma samples analysis Sponsor: Janssen-Cilag Farmaceutica Ltda. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2020 Category: Research Source Type: clinical trials

Apalutamide, Abiraterone Acetate, and Prednisone for the Treatment of Metastatic High Risk Castration Sensitive Prostate Cancer
Conditions: Castration-Sensitive Prostate Carcinoma; Metastatic Prostate Carcinoma; Stage IV Prostate Cancer AJCC v8; Stage IVA Prostate Cancer AJCC v8; Stage IVB Prostate Cancer AJCC v8 Interventions: Drug: Abiraterone Acetate; Drug: Antiandrogen Therapy; Drug: Apalutamide; Drug: Prednisone; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: OHSU Knight Cancer Institute; National Cancer Institute (NCI); Oregon Health and Science University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2020 Category: Research Source Type: clinical trials